What is sufficient evidence for the reliability and validity of patient-reported outcome measures?

被引:381
|
作者
Frost, Marlene H.
Reeve, Bryce B.
Liepa, Astra M.
Stauffer, Joseph W.
Hays, Ron D.
Sloan, Jeff A.
机构
[1] Mayo Clin, Womens Canc Program, Rochester, MN USA
[2] NCI, Div Canc Control & Populat Sci, Outcomes Res Branch, Appl Res Program, Bethesda, MD 20892 USA
[3] Eli Lilly & Co, Global Hlth Outcomes, Indianapolis, IN 46285 USA
[4] Alpharma, Global Med Affairs, Piscataway, NJ USA
[5] Univ Calif Los Angeles, Dept Hlth Sci, Dept Med, UCLA Div Gen Internal Med & Hlth Ser Res, Los Angeles, CA USA
[6] RAND Corp, Santa Monica, CA USA
关键词
patient-reported outcomes; psychometric; validation;
D O I
10.1111/j.1524-4733.2007.00272.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
This article focuses on the necessary psychometric properties of a patient-reported outcomes (PROs) measure. Topics include the importance of reliability and validity, psychometric approaches used to provide reliability and validity estimates, the kinds of evidence needed to indicate that a PRO has a sufficient level of reliability and validity, contexts that may affect psychometric properties, methods available to evaluate PRO instruments when the context varies, and types of reliability and validity testing that are appropriate during different phases of clinical trials. Points discussed include the perspective that the psychometric properties of reliability and validity are on a continuum in which the more evidence one has, the greater confidence there is in the value of the PRO data. Construct validity is the type of validity most frequently used with PRO instruments as few "gold standards" exist to allow the use of criterion validity and content validity by itself only provides beginning evidence of validity. Several guidelines are recommended for establishing sufficient evidence of reliability and validity. For clinical trials, a minimum reliability threshold of 0.70 is recommended. Sample sizes for testing should include at least 200 cases and results should be replicated in at least one additional sample. At least one full report on the development of the instrument and one on the use of the instrument are deemed necessary to evaluate the PRO psychometric properties. Psychometric testing ideally occurs before the initiation of Phase III trials. When testing does not occur prior to a Phase III trial, considerable risk is posed in relation to the ability to substantiate the use of the PRO data. Various qualitative (e.g., focus groups, behavioral coding, cognitive interviews) and quantitative approaches (e.g., differential item functioning testing) are useful in evaluating the reliability and validity of PRO instruments.
引用
收藏
页码:S94 / S105
页数:12
相关论文
共 50 条
  • [1] Evaluation of Validity, Reliability, and Feasibility of 3 Patient-Reported Foot and Ankle Outcome Measures
    Venkatesan, Murali
    Aziz, Sheweidin
    Mahadevan, Dev
    Korim, Tawfiq
    Dias, Joe
    Bhatia, Maneesh
    JOURNAL OF FOOT & ANKLE SURGERY, 2020, 59 (03) : 507 - 512
  • [2] A systematic review of the validity and reliability of patient-reported experience measures
    Bull, Claudia
    Byrnes, Joshua
    Hettiarachchi, Ruvini
    Downes, Martin
    HEALTH SERVICES RESEARCH, 2019, 54 (05) : 1023 - 1035
  • [3] Selecting patient-reported outcome measures: "what" and "for whom"
    Liu, Jason B.
    Rothrock, Nan E.
    Edelen, Maria O.
    HEALTH AFFAIRS SCHOLAR, 2024, 2 (04):
  • [4] Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
    van Dijkhuizen, E. H. Pieter
    Ridella, Francesca
    Naddei, Roberta
    Trincianti, Chiara
    Avrusin, Ilia
    Mazzoni, Marta
    Sutera, Diana
    Ayaz, Nuray Aktay
    Penades, Inmaculada Calvo
    Constantin, Tamas
    Herlin, Troels
    Oliveira, Sheila K.
    Rygg, Marite
    Sanner, Helga
    Susic, Gordana
    Sztajnbok, Flavio
    Varbanova, Boriana
    Ruperto, Nicolino
    Ravelli, Angelo
    Consolaro, Alessandro
    ARTHRITIS CARE & RESEARCH, 2023, 75 (02) : 391 - 400
  • [5] The Validity of Patient-Reported Outcome Measures of Quality of Life in Palliative Care: A Systematic Review
    Li, Yifan
    Hung, Vivian
    Ho, Kevin
    Kavalieratos, Dio
    Warda, Nahrain
    Zimmermann, Camilla
    Quinn, Kieran
    JOURNAL OF PALLIATIVE MEDICINE, 2024, 27 (04) : 545 - 562
  • [6] Patient-reported Outcome Measures - A Call for More Narrative Evidence
    Meadows, Keith
    JOURNAL OF PATIENT EXPERIENCE, 2021, 8
  • [7] Patient-Reported Outcomes (Pros) and Patient-Reported Outcome Measures (Proms)
    Weldring, Theresa
    Smith, Sheree M. S.
    HEALTH SERVICES INSIGHTS, 2013, 6 : 61 - 68
  • [8] Performance-based and patient-reported outcome measures for custom ankle-foot orthosis users: reliability, validity, and sensitivity evidence
    Heinemann, Allen W.
    Fatone, Stefania
    Lavela, Sherri L.
    Deutsch, Anne
    Peterson, Michelle
    Slater, Billie C. S.
    Kale, Ibuola O.
    Soltys, Nicole T.
    Mcpherson, Vari
    Mccombs, Nicholas
    DISABILITY AND REHABILITATION, 2025,
  • [9] Patient-reported outcome measures for lupus nephritis: content validity of LupusQoL and FACIT-Fatigue
    Martin, Mona L.
    Hill, Jennifer N.
    Rogers, Jennifer L.
    Chauhan, Deven
    Chen, Wen-Hung
    Gairy, Kerry
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
  • [10] Application of validity theory and methodology to patient-reported outcome measures (PROMs): building an argument for validity
    Hawkins, Melanie
    Elsworth, Gerald R.
    Osborne, Richard H.
    QUALITY OF LIFE RESEARCH, 2018, 27 (07) : 1695 - 1710